The Trans-Pacific Partnership Is Designed to Increase Some Barriers

A NYT article on growing Congressional opposition to the Trans-Pacific Partnership (TPP) told readers;

"The T.P.P. as outlined is aimed at reducing barriers, cutting red tape and harmonizing international regulations,.."

It is not true that the TPP is designed simply to reduce barriers. The provisions on patent monopolies for prescription drugs and related protections like data exclusivity will almost certainly increase barriers and raise prices. This is likely to be the case with its copyrig...